148 related articles for article (PubMed ID: 31011396)
21. Prevalence of beryllium sensitization among aluminium smelter workers.
Taiwo OA; Slade MD; Cantley LF; Kirsche SR; Wesdock JC; Cullen MR
Occup Med (Lond); 2010 Oct; 60(7):569-71. PubMed ID: 20610489
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of serial medical surveillance for chronic beryllium disease in a beryllium machining plant.
Newman LS; Mroz MM; Maier LA; Daniloff EM; Balkissoon R
J Occup Environ Med; 2001 Mar; 43(3):231-7. PubMed ID: 11285871
[TBL] [Abstract][Full Text] [Related]
23. Recent advances in understanding the biomolecular basis of chronic beryllium disease: a review.
McCleskey TM; Buchner V; Field RW; Scott BL
Rev Environ Health; 2009; 24(2):75-115. PubMed ID: 19658317
[TBL] [Abstract][Full Text] [Related]
24. A study on the beryllium lymphocyte transformation test and the beryllium levels in working environment.
Yoshida T; Shima S; Nagaoka K; Taniwaki H; Wada A; Kurita H; Morita K
Ind Health; 1997 Jul; 35(3):374-9. PubMed ID: 9248221
[TBL] [Abstract][Full Text] [Related]
25. Recent chronic beryllium disease in residents surrounding a beryllium facility.
Maier LA; Martyny JW; Liang J; Rossman MD
Am J Respir Crit Care Med; 2008 May; 177(9):1012-7. PubMed ID: 18244954
[TBL] [Abstract][Full Text] [Related]
26. [Management of occupational health for adverse health effects of beryllium and its compounds in workplaces - Recent trends and issues in Japan].
Toyooka T; Koda S
Sangyo Eiseigaku Zasshi; 2021 Mar; 63(2):31-42. PubMed ID: 32788509
[TBL] [Abstract][Full Text] [Related]
27. HLA-DPB1 E69 genotype and exposure in beryllium sensitisation and disease.
Crooks J; Mroz MM; VanDyke M; McGrath A; Schuler C; McCanlies EC; Virji MA; Rosenman KD; Rossman M; Rice C; Monos D; Fingerlin TE; Maier LA
Occup Environ Med; 2022 Feb; 79(2):120-126. PubMed ID: 34535537
[TBL] [Abstract][Full Text] [Related]
28. Beryllium lymphocyte proliferation test surveillance identifies clinically significant beryllium disease.
Mroz MM; Maier LA; Strand M; Silviera L; Newman LS
Am J Ind Med; 2009 Oct; 52(10):762-73. PubMed ID: 19681064
[TBL] [Abstract][Full Text] [Related]
29. Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease.
Mroz MM; Kreiss K; Lezotte DC; Campbell PA; Newman LS
J Allergy Clin Immunol; 1991 Jul; 88(1):54-60. PubMed ID: 2071785
[TBL] [Abstract][Full Text] [Related]
30. Beryllium exposure and chronic beryllium disease.
Infante PF; Newman LS
Lancet; 2004 Feb; 363(9407):415-6. PubMed ID: 14962519
[No Abstract] [Full Text] [Related]
31. Beryllium: a modern industrial hazard.
Kreiss K; Day GA; Schuler CR
Annu Rev Public Health; 2007; 28():259-77. PubMed ID: 17094767
[TBL] [Abstract][Full Text] [Related]
32. Clinical and laboratory factors contributing to uninterpretable beryllium lymphocyte proliferation tests (BeLPT).
Smith DE; Golden AP; Stange AW; Barker E; Mroz M; Barón AE; Ghosh D; Maier L; Cragle D; Newman LS
Am J Ind Med; 2018 Jul; 61(7):592-604. PubMed ID: 29574954
[TBL] [Abstract][Full Text] [Related]
33. A Cluster of Beryllium Sensitization Traced to the Presence of Beryllium in Concrete Dust.
Frye BC; Quartucci C; Rakete S; Grubanovic A; Höhne K; Mangold F; Gieré R; Müller-Quernheim J; Zissel G
Chest; 2021 Mar; 159(3):1084-1093. PubMed ID: 32926872
[TBL] [Abstract][Full Text] [Related]
34. Long-term follow-up of beryllium sensitized workers from a single employer.
Duggal M; Deubner DC; Curtis AM; Cullen MR
BMC Public Health; 2010 Jan; 10():5. PubMed ID: 20047684
[TBL] [Abstract][Full Text] [Related]
35. Measurement of beryllium in lung tissue of a chronic beryllium disease case and cases with sarcoidosis.
Verma DK; Ritchie AC; Shaw ML
Occup Med (Lond); 2003 May; 53(3):223-7. PubMed ID: 12724557
[TBL] [Abstract][Full Text] [Related]
36. Search for chronic beryllium disease among sarcoidosis patients in Ontario, Canada.
Ribeiro M; Fritscher LG; Al-Musaed AM; Balter MS; Hoffstein V; Mazer BD; Maier LA; Liss GM; Tarlo SM
Lung; 2011 Jun; 189(3):233-41. PubMed ID: 21400234
[TBL] [Abstract][Full Text] [Related]
37. Clinical approach to chronic beryllium disease and other nonpneumoconiotic interstitial lung diseases.
Maier LA
J Thorac Imaging; 2002 Oct; 17(4):273-84. PubMed ID: 12362066
[TBL] [Abstract][Full Text] [Related]
38. Assessment of the beryllium lymphocyte proliferation test using statistical process control.
Cher DJ; Deubner DC; Kelsh MA; Chapman PS; Ray RM
Inhal Toxicol; 2006 Oct; 18(11):901-10. PubMed ID: 16864408
[TBL] [Abstract][Full Text] [Related]
39. Beryllium medical surveillance at a former nuclear weapons facility during cleanup operations.
Sackett HM; Maier LA; Silveira LJ; Mroz MM; Ogden LG; Murphy JR; Newman LS
J Occup Environ Med; 2004 Sep; 46(9):953-61. PubMed ID: 15354061
[TBL] [Abstract][Full Text] [Related]
40. Identification of an abnormal beryllium lymphocyte proliferation test.
Frome EL; Newman LS; Cragle DL; Colyer SP; Wambach PF
Toxicology; 2003 Feb; 183(1-3):39-56. PubMed ID: 12504341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
